Purchase Order 75N98026P00203
Award Date 4/16/26
Potential Completion Date 4/15/29
Potential Value $119K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart Lung and Blood Institute (NHLBI) awarded a maintenance contract to Becton, Dickinson and Company's BD Biosciences division for the BD Fortessa Flow Cytometer Analyzer on February 1, 2026. This firm fixed-price purchase order, valued at $42,476.04 with completion scheduled for January 31, 2027, supports the NHLBI's biomedical research infrastructure. The contract covers maintenance services for the BD Fortessa, a sophisticated flow cytometry instrument used in cellular and...
- The National Heart Lung and Blood Institute (NHLBI) awarded a $122,622.24 firm fixed-price purchase order to Becton, Dickinson and Company's BD Biosciences division for a maintenance agreement covering a BD LSRFortessa flow cytometry system equipped with four lasers (blue, red, violet, and ultraviolet) and one computer workstation. The contract was awarded on May 26, 2025, with an ultimate completion date of May 25, 2029, and will be performed at the NHLBI's location in Bethesda, Maryland. No...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a Delivery Order contract to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for maintenance and service support of an LSRFortessa flow cytometry instrument. Valued at $52,736.04 with a firm fixed-price structure, this contract will support the NHLBI's Flow Cytometry Core facility, a state-of-the-art resource dedicated to enabling biomedical research conducted by NHLBI investigators. The...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order to Becton, Dickinson and Company (BD), through its BD Biosciences division, for maintenance services on the NHLBI Directorate's Flow Cytometry Core FACSymphony A5 instrument. This $48,097.92 firm fixed-price contract, with no set-aside designation, runs through December 31, 2026, and represents a continuation of maintenance support for critical research instrumentation. As a child contract under BD's larger federal...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $53,205.12 to Becton, Dickinson and Company (BD Biosciences) on January 1, 2026, for maintenance coverage of its LSRFortessa flow cytometry system and throughput sampler. This firm fixed-price contract, which serves as a child delivery order under a larger indefinite delivery vehicle, will be performed in San Jose, California and is scheduled for completion by December 31, 2026. The award was made without...
- On January 13, 2025, the National Heart Lung and Blood Institute (NHLBI) awarded a firm fixed-price purchase order valued at $51,828.84 to Becton, Dickinson and Company's BD Biosciences division for maintenance services on a Fortessa flow cytometer analyzer. The contract, designated as part of the FY26 UDO Initiative, has an ultimate completion date of January 12, 2026, and will be performed in San Jose, California. This award requires no small business set-aside and represents a child...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
- Becton, Dickinson and Company's BD Biosciences division was awarded a $201,042 firm fixed-price purchase order by the National Heart Lung and Blood Institute (NHLBI) on April 1, 2025, for the Service Agreement Symphony A3 and Lasers. The contract, which operates without a small business set-aside, has an ultimate completion date of March 31, 2030, and will be performed in Bethesda, Maryland. Based on BD Biosciences' established federal contract portfolio, this award likely encompasses...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $22,107.60 firm fixed-price purchase order to Becton, Dickinson and Company's BD Biosciences division for instrument service contract support to the Flow Cytometry Core facility. The single award contract, effective February 1, 2026 through January 31, 2027, provides maintenance and technical support services essential to sustaining the state-of-the-art flow cytometry facility that supports biomedical research conducted by NHLBI...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...